Talk: Neuroprotective drug discovery based on TCM clinical practice

Prof. Min Li obtained a bachelor’s degree from Henan University of Chinese Medicine in 1985, a master’s degree from Guangzhou University of Chinese Medicine in 1988 in China, and a PhD degree from School of Medicine, Tokai University in 2001 in Japan. Prof. Li currently is the Director of Teaching and Research Division in the School of Chinese Medicine (SCM), Hong Kong Baptist University (HKBU); she is also the Director of Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research and an Associate Director of the Clinical Division in SCM, HKBU. Prof. Li’s research focuses on the neuroprotective effects and molecular mechanisms of traditional Chinese medicine (TCM) on neurodegenerative diseases, especially on Parkinson's disease (PD) and Alzheimer's disease (AD), her research also including clinical study of the efficacy and safety of TCM in the treatment of PD and AD, as well as on the drug discovery of natural autophagy-lysosome modulators from TCM for neurodegenerations. Prof. Li was awarded as the distinguished female Chinese medicine practitioner by the China Association of Chinese medicine in 2007; she has published 20 books, around 100 scientific research papers, and over 140 oral or poster presentations in the international conferences and obtained several US patents.